Pharmaceutical company Medarex Inc. said Monday it will offer 10 million shares of stock in a secondary offering to finance product development and research. Goldman, Sachs & Co. is underwriting the offering, with J.P. Morgan Securities Inc. acting as manager. The company said other firms may co-manage the sale. The underwriters will be granted options for 1.5 million additional shares, Medarex said.
The Houston Chronicle (http://www.chron.com/disp/story.mpl/ap/fn/3766753.html)